Advertisement

Topics

Latest "International PBI S.p.A" News Stories

14:03 EST 16th January 2019 | BioPortfolio

Here are the most relevant search results for "International PBI S.p.A" found in our extensive news archives from over 250 global news sources.

More Information about International PBI S.p.A on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about International PBI S.p.A for you to read. Along with our medical data and news we also list International PBI S.p.A Clinical Trials, which are updated daily. BioPortfolio also has a large database of International PBI S.p.A Companies for you to search.

Showing "International" News Articles 1–25 of 5,400+

Wednesday 16th January 2019

Conversio Health Announces Leadership Transition and Appointment of Tom Frosheiser as CEO and Member of the Board of Directors

Conversio Health welcomes accomplished healthcare executive Tom Frosheiser THE WOODLANDS, Texas (PRWEB) January 16, 2019 Tom Frosheiser has joined Conversio Health as CEO and member of the company’s board of directors. Mr. Frosheiser succeeds co-founder and former CEO, Kirk Clove who will remain on Conversio Health’s board of directors and serve as a strategic advisor to the company. Mr. Clov...


CRISPR Aids Fight Against Neglected Tropical Diseases

As a whole, parasitic diseases affect an exorbitant number of people worldwide but are often overlooked as they are rare in more developed regions. Additionally, many of these neglected diseases have unusual pathology, making them incredibly difficult to manage therapeutically. Yet now, an international team of investigators led by scientists at George Washington University (GW) […] The post...

NextGen Healthcare, Inc. to Host Fiscal 2019 Third Quarter Results Conference Call

NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused healthcare technology solutions, will release its fiscal 2019 third quarter ended December 31, 2018 operating results on Wednesday, January 23, 2019 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. Shareholders and interested participan...


Susan Ludwick Joins Eyecare Services Partners as Senior Vice President of Optical Services

Eyecare Services Partners (ESP), the national leader in integrated eye care services, announced the appointment of Susan Ludwick as Senior Vice President of Optical Services. Ms. Ludwick brings over 25 years of optical industry leadership experience to ESP. Most recently she was with Refac Optical Group where she was Senior Vice President, Brand M...

Groundbreaking Danish-US MedTech Partnership Kicks off in Medical Alley

A delegation of Denmark’s medtech and health leaders are in Medical Alley this week solidifying a first-of-its-kind MedTech Bridge partnership with the United States. MedTech Bridge is a new program established to open the door for medical device and digital health companies in Denmark looking to create operations in the United States. This press release ...

Microbes Are Fighting for Survival on the International Space Station

ArticleMicrobes are adapting to survive—not to cause disease—on the International Space Station.Staff Author: 

Jeff Stute Joins Perella Weinberg Partners as Partner

Further Strengthens Firm’s Advisory and Global Healthcare Franchise Perella Weinberg Partners (“PWP”) today announced that Jeff Stute has joined the Firm as a Partner in its Advisory business. Based in New York, he will work closely with the Firm’s global healthcare team, including Partners Chris O’Connor, Philippe McAuliffe, Nick Johnston, a...

Janssen announces European Commission approval of ERLEADA® (apalutamide) for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease

Phase 3 SPARTAN data served as basis for approval, which showed apalutamide decreased the risk of distant metastasis or death by 72 percent and improved median metastasis-free survival by more than two years1 The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the European Commission (EC) has granted...

Charles River Laboratories Selected for 2019 Bloomberg Gender-Equality Index

The 2019 Gender-Equality Index highlights 230 firms that are trailblazers in their commitment to gender diversity in the workplace Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it is pleased to have been selected as one of 230 companies for the 2019 Bloomberg Gender-Equality Index (GEI), which distinguishes companies c...

Tenet and Anthem Blue Cross Sign Multi-Year Agreement

Tenet Healthcare Corporation (NYSE:THC) and Anthem Blue Cross (Anthem) today announced that they have signed a new multi-year agreement, providing Anthem Blue Cross members with continued in-network access to Tenet’s California facilities and other providers. Ron Rittenmeyer, Tenet’s Executive Chairman and Chief Executive Officer, said, “We ...

Ventas Announces Fourth Quarter and Year-End 2018 Earnings Release Date and Conference Call

Ventas, Inc. (NYSE: VTR) will issue its fourth quarter and year-end 2018 earnings release prior to the opening of trading on the New York Stock Exchange on Friday, February 8, 2019. A conference call to discuss those earnings will be held the same day at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the conference call i...

Opioid prescribing highest in more deprived regions of England, study shows

Opioid prescribing in general practice is highest in the North West of England and the East Midlands, mirroring general geographical health inequalities, a study published in the International Journal of Drug Policy has found.

World Courier Achieves Good Distribution Practice Certification across its Global Network

Awarded by DQS, a leading certification body for management systems worldwide, the certificate underscores World Courier’s commitment to and compliance with quality management standards and international requirements throughout the supply chain. The company received the certification following a six–month long evaluation process, during which a team of DQS auditors analyzed World Couri...

Boyds awarded Queen’s Award for Enterprise

Boyds, a leading consultancy business supporting the development of pharmaceutical and biotech products and devices for patient benefit, has today been recognised with one of the UK’s most prestigious business awards – The Queen’s Award for Enterprise, International Trade for Outstanding Short Term Growth in overseas sales for the last three years. Boyds was established 13 years ...

Director appointed to Health Innovation Campus

Lancaster University is pleased to announce that Dr Sherry Kothari will be the new Director of its Health Innovation Campus. She will join the University in September to lead the Health Innovation Campus (HIC) where health experts will work collaboratively with businesses and the health sector to tackle the biggest challenge in healthcare today - helping people to live as long and as healthily as...

A Startup Competition Like No Other: The Startup Slam at BIO Europe 2018!

“The Startup Slam provides an excellent opportunity for early stage companies to gain exposure to an international audience of potential partners and investors,” says Kari Bennett, Vice President of Marketing at EBD Group. Together with Johnson & Johnson Innovation, EBD ... The post A Startup Competition Like No Other: The Startup Slam at BIO Europe 2018! appeared first on Labiotech.eu.

Aino Health AB (publ): Aino Health signs agreement with global customer service company

January 16 2019Aino Health has signed an agreement regarding Aino HealthManager with a global company in customer service. The agreement encompasses more than 450 new licenses for Aino's SaaS solution HealthManager in Sweden and Norway. The agreement pertains to a pilot project running for six months within parts of the Swedish and Norwegian operations. After that, there is an...

Cobra Biologics announces appointment of Dr Darrell Sleep as Director of Innovation

Cobra Biologics, an international CDMO for biologics and pharmaceuticals, today announced the appointment of Dr Darrell Sleep as Director of Innovation.

KYOCERA to Purchase Major Assets of U.S.-based Renovis Surgical Technologies, Inc.

Kyocera Corporation (TOKYO:6971) today announced that its U.S. headquarters, Kyocera International, Inc., has finalized an agreement with Renovis Surgical Technologies, Inc. (herein “Renovis”), a U.S.-based orthopedic and spinal medical device manufacturer and developer, to purchase the major assets of Renovis’ business operations relating to artific...

Tuesday 15th January 2019

Cellular protein a target for Zika control

(Penn State) A cellular protein that interacts with invading viruses appears to help enable the infection process of the Zika virus, according to an international team of researchers who suggest this protein could be a key target in developing new therapies to prevent or treat Zika virus infection.

First international consensus on fibromuscular dysplasia

(SAGE) The "First international consensus on the diagnosis and management of fibromuscular dysplasia" (FMD) has been published online first today in Vascular Medicine and the Journal of Hypertension.

Omega Announces Quarterly Common Stock Dividend and Schedules Fourth Quarter Earnings Release Date and Conference Call

Omega Healthcare Investors, Inc. (NYSE:OHI) today announced that the Company’s Board of Directors declared a common stock dividend of $0.66 per share. The common stock dividend is payable Friday, February 15, 2019 to common stockholders of record as of the close of business on Thursday, January 31, 2019. Fourth Quarter Earnings Release and Confe...

SK Capital Announces Promotions

SK Capital Partners, a private investment firm focused exclusively on the specialty materials, chemicals and pharmaceuticals sectors, announced today several promotions. Barry Penney has been promoted to Managing Director after joining SK Capital as a Principal in 2015. Mr. Penney spent over thirty years as an executive in domestic and internation...

Medicare IPI Model Could Import Benefit Of Biosimilar Competition, Azar Suggests

HHS secretary notes Medicare Part B International Pricing Index could ‘harness’ biosimilar price competition seen abroad for US market, where...  

Ligand to Report Fourth Quarter and Full Year 2018 Results on February 7th

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced today plans to report fourth quarter and full year 2018 financial results on February 7, 2019. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. Fourth Quarter and Full Year 2018 Earnings Call ...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks